Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
32.47
+0.78 (2.46%)
Mar 28, 2025, 3:04 PM CST
SHE:002422 Revenue
Sichuan Kelun Pharmaceutical had revenue of 4.96B CNY in the quarter ending September 30, 2024, with 0.35% growth. This brings the company's revenue in the last twelve months to 22.50B, up 7.96% year-over-year. In the year 2023, Sichuan Kelun Pharmaceutical had annual revenue of 21.45B with 12.69% growth.
Revenue (ttm)
22.50B
Revenue Growth
+7.96%
P/S Ratio
2.23
Revenue / Employee
1.14M
Employees
19,798
Market Cap
51.51B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 21.45B | 2.42B | 12.69% |
Jan 1, 2023 | 19.04B | 1.76B | 10.19% |
Jan 1, 2022 | 17.28B | 813.21M | 4.94% |
Dec 31, 2020 | 16.46B | -1.17B | -6.65% |
Dec 31, 2019 | 17.64B | 1.28B | 7.86% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |